| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing cetuximab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetuximab (substance) |
Inferred relationship |
Some |
1 |
| Cetuximab 2mg/mL injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetuximab (substance) |
Inferred relationship |
Some |
|
| Product containing only cetuximab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetuximab (substance) |
Inferred relationship |
Some |
1 |
| allergie au cetuximab |
Causative agent (attribute) |
False |
Cetuximab (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely cetuximab 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cetuximab (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely cetuximab 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cetuximab (substance) |
Inferred relationship |
Some |
1 |
| Cetuximab-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetuximab (substance) |
Inferred relationship |
Some |
1 |
| Cetuximab only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cetuximab (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely cetuximab 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cetuximab (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely cetuximab 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cetuximab (substance) |
Inferred relationship |
Some |
1 |
| Cetuximab 5 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cetuximab (substance) |
Inferred relationship |
Some |
1 |
| Cetuximab 5 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cetuximab (substance) |
Inferred relationship |
Some |
1 |
| Cetuximab 5 mg/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cetuximab (substance) |
Inferred relationship |
Some |
1 |
| Cetuximab 5 mg/mL solution for infusion and/or injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cetuximab (substance) |
Inferred relationship |
Some |
1 |
| Allergy to cetuximab due to alpha-gal syndrome (finding) |
Causative agent (attribute) |
True |
Cetuximab (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]